TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic LiverReport as inadecuate

TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver - Download this document for free, or read online. Document in PDF available to download.


The development of hepatocellular carcinoma HCC is a common consequence of advanced liver fibrosis but the interactions between fibrogenesis and carcinogenesis are still poorly understood. Recently it has been shown that HCC promotion depends on Toll-like receptor TLR 4. Pre-cancerogenous events can be modelled in mice by the administration of a single dose of diethylnitrosamine DEN, with HCC formation depending amongst others on interleukin IL 6 production. Mice lacking the hepatocanalicular phosphatidylcholine transporter ABCB4 develop liver fibrosis spontaneously, resemble patients with sclerosing cholangitis due to mutations of the orthologous human gene, and represent a valid model to study tumour formation in pre-injured cholestatic liver. The aim of this study was to investigate DEN-induced liver injury in TLR4-deficient mice with biliary fibrosis.


ABCB4-deficient mice on the FVB-NJ genetic background were crossed to two distinct genetic backgrounds TLR4-sufficient C3H-HeN and TLR4-deficient C3H-HeJ for more than 10 generations. The two congenic knockout and the two corresponding wild-type mouse lines were treated with a single dose of DEN for 48 hours. Phenotypic differences were assessed by measuring hepatic collagen contents, inflammatory markers ALT, CRP, IL6 as well as hepatic apoptosis TUNEL and proliferation Ki67 rates.


Hepatic collagen accumulation is significantly reduced in ABCB4-:TLR4-double-deficient mice. After DEN challenge, apoptosis, proliferation and inflammatory markers are decreased in TLR4-deficient in comparison to TLR4-sufficient mice. When combining ABCB4 and TLR4 deficiency with DEN treatment, hepatic IL6 expression and proliferation rates are lowest in fibrotic livers from the double-deficient line. Consistent with these effects, selective digestive tract decontamination in ABCB4- mice also led to reduced tumor size and number after DEN.


This study demonstrates that liver injury upon DEN challenge depends on pre-existing fibrosis and genetic background. The generation of ABCB4-: TLR4- double-deficient mice illustrates that TLR4-deficiency protects against hepatic injury in a preclinical mouse model of chronic liver disease.

Author: Susanne Nicole Weber, Annika Bohner, Dianne H. Dapito, Robert F. Schwabe, Frank Lammert



Related documents